Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial

NCT06228794

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With Recurrent/Refractory Light Chain Amyloidosis

NCT06983951

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: Beijing Gobroad Brond Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT05759793

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine Shanghai, China

View Trial Details

Recruiting

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

NCT06971380

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +24 more
Locations: Hadassah MO Jerusalem, Israel

View Trial Details

Recruiting

Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma

NCT05294055

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Anhui Provincial Hospital Hefei, Anhui, China

Peking University Third Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, Henan, China

Shandong Cancer Hospital Jinan, Shandong, China

View Trial Details

Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT05908409

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations: Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain

Hospital Universitario de Salamanca Salamanca, Castille and León, Spain

Hospital Universitari Vall d'hebron Barcelona, Spain

Hospital Durán i Reynals - ICO L´Hospitalet Barcelona, Spain

View Trial Details

Recruiting

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

NCT06699394

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: Peking University Peoples Hospital Beijing, Beijing Municipality, China

Fuxing Hospital affiliated to Capital Medical University Beijing, China

View Trial Details

Recruiting

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

NCT05956457

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: University of Washington Seattle, Washington, United States

View Trial Details

Recruiting

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

NCT06140966

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Multiple Myeloma, +14 more
Locations: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

NCT05945524

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CHU d'Amiens Amiens, France

CHU de Caen Caen, France

Polyclinique du Parc Drevon Dijon, France

CH Annecy Genevois Epagny Metz- Tessy, France

View all 18 locations

View Trial Details